Skip to content
TrustList
Qbic Fund logo
Venture capital firm

Qbic Fund

Inter-university venture fund turning research breakthroughs from Belgian institutes into new companies

Qbic Fund cover

About Qbic Fund

Research spin-offs from Belgian universities are the focus of Qbic, an inter-university venture capital fund. Qbic turns technological breakthroughs into sustainable businesses, and its strategy is to move research into commercial products through funds, knowledge partners and early investment.

Three funds and the early-stage pipeline

Qbic I and Qbic II continue to back companies in their portfolios. Qbic III provides pre-seed funding for new science-based companies, including a recent pre-seed round for a biosciences company. Knowledge partners at universities and research groups help the fund find and shape spin-offs.

Photonics and medical technology from Ghent

Several companies trace back to photonics research at Ghent University and imec, in the cluster known as Photonics Valley. Indigo is developing an implantable sensor that uses spectroscopy and silicon photonics to measure glucose and other metabolites continuously for up to two years, sending readings to an app. Unlike skin patches that rely on enzymes and last a week or two, the sensor is designed for a much longer life, and the company reports that it is being tested in humans. Eyeo develops colour-splitting photonics for compact, high-performance imaging.

Sensing, robotics and therapeutics

VoxelSensors develops ultra-low-power, low-latency 3D perception sensors for extended reality. AILOS Robotics makes actuation for robotics using a patented gearbox. Sentea works on fibre-optic sensing for industrial use, and Aloxy applies Internet of Things technology to the petrochemical industry. Obulytix develops enzyme-based antibiotics inspired by nature, Animab develops antibodies for livestock against gastrointestinal pathogens, and Tanai Therapeutics is developing a first-in-class oral treatment for obesity.

Software, clinical and AI companies

Sightera Biosciences, one of the companies in the portfolio, works on an AI drug discovery platform and a set of therapeutic assets. Pleevi provides AI-driven smart charging for electric vehicles, and a further portfolio company offers alerts that help clinicians spot patient deterioration sooner. THERAtRAME develops therapeutics that target tRNA epitranscriptomics in cancer.

TrustList summary

Qbic is an inter-university venture capital fund that turns technological breakthroughs into sustainable businesses. Its funds have backed spin-offs from research groups, several of them linked to photonics work in Ghent.

What Qbic offers

  • Early-stage funding: Its third fund has provided pre-seed money to new science-based companies.
  • Multiple funds: The first and second funds continue to back companies in the portfolio.
  • Knowledge partners: The firm works with university and research partners to find and shape spin-offs.
  • Investment strategy: Its stated approach is to move research into commercial products.

Customers and markets

The portfolio covers health and deep technology. Companies include an implantable glucose sensor, an AI drug discovery platform, robotics gearboxes, a patient-monitoring alert tool, smart charging for electric vehicles, an obesity treatment, colour-splitting image sensors, enzyme-based antibiotics, 3D perception sensors for extended reality and antibodies for livestock.

Key facts

  • Type: Inter-university venture capital fund
  • Focus: Deep tech, life sciences and photonics
  • Funds: At least three

Summary written by TrustList from the business's own published information, Nov 2026.

Categories & features

  • Business
  • Internet
  • It
  • Digital
  • Production
  • Medical

Ask TrustList to introduce you to Qbic Fund

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA - Google Privacy Policy and Terms apply.

Reviews

Write the first review of Qbic Fund

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Qbic Fund.

Qbic Fund alternatives

Similar listings buyers compare against this one.

Africa-focused investor that funds and mentors entrepreneurs, backed by the Chandaria Group of Companies

Impact investor backing early-stage technology startups that address the UN sustainable development goals

California private equity investor putting expansion capital into mid-sized software and technology-enabled businesses

Early-stage venture capital investor working closely with a small number of founders

Multi-stage investor with offices in Newport Beach and New York backing healthtech, fintech, proptech and mobility

New York boutique venture firm investing in growth-stage technology companies across several sectors

Investment bank advising digital media and marketing companies on mergers, acquisitions and strategic deals

Early-stage investor supporting capital-efficient founders in North America from pre-seed to Series B